Mineralys CMO David Malcom Rodman disposes of 416 common shares worth $11,036.48
MLYS•Mineralys CMO share transaction
- Mineralys Therapeutics Chief Medical Officer David Malcom Rodman sold 416 common shares at $26.53 on July 17, 2026.
- He exercised stock options for 416 shares at $15.44 the same day.
- He held 51,384 common shares following the transactions.
